APA (7th ed.) Citation

Ciobotariu, I., Stefani, A. D., Paradisi, A., Nardo, L. D., & Peris, K. Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting. Elsevier.

Chicago Style (17th ed.) Citation

Ciobotariu, I., A. Di Stefani, A. Paradisi, L. Di Nardo, and K. Peris. Neutrophil-lymphocyte Ratio as a Predictive Marker for Progression Free Survival in Patients with Advanced Cutaneous Squamous Cell Carcinoma Prior to Cemiplimab Treatment – a Real-life Setting. Elsevier.

MLA (9th ed.) Citation

Ciobotariu, I., et al. Neutrophil-lymphocyte Ratio as a Predictive Marker for Progression Free Survival in Patients with Advanced Cutaneous Squamous Cell Carcinoma Prior to Cemiplimab Treatment – a Real-life Setting. Elsevier.